| Epidemiology | Lifetime | 46 | US 25 | 99.92 |
| Medical Physiology | Lifetime | 154 | US 87 | 99.77 |
| Cell Biology | Lifetime | 150 | US 95 | 99.22 |
| Endocrine and Autonomic Systems | Lifetime | 373 | US 185 | 93.65 |
| Epidemiology | 2021-2025 | 164 | US 53 | 98.94 |
| Molecular Biology | 2021-2025 | 518 | US 146 | 97.34 |
| Medical Physiology | 2021-2025 | 257 | US 89 | 96.57 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 690 | US 300 | 87.41 |
| Cellular and Molecular Neuroscience | 2021-2025 | 377 | US 152 | 38.22 |
| Adipose Tissue and Metabolism | Lifetime | 6 | US 4 | 99.96 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 4 | US 3 | 99.95 |
| Cardiovascular Disease and Adiposity | Lifetime | 17 | US 14 | 99.88 |
| Caveolin-1 and cellular processes | Lifetime | 4 | US 1 | 99.80 |
| Lipid metabolism and disorders | Lifetime | 10 | US 5 | 99.71 |
| Regulation of Appetite and Obesity | Lifetime | 39 | US 22 | 99.54 |
| Metabolism, Diabetes, and Cancer | Lifetime | 74 | US 38 | 99.61 |
| Erythrocyte Function and Pathophysiology | Lifetime | 68 | US 47 | 99.14 |
| Biomarkers in Disease Mechanisms | Lifetime | 44 | US 8 | 97.53 |
| Pancreatic function and diabetes | Lifetime | 748 | US 316 | 98.01 |
| Signaling Pathways in Disease | Lifetime | 267 | US 139 | 97.08 |
| Lipid metabolism and biosynthesis | Lifetime | 372 | US 165 | 96.60 |
| Fibroblast Growth Factor Research | Lifetime | 415 | US 181 | 94.67 |
| Peroxisome Proliferator-Activated Receptors | Lifetime | 918 | US 387 | 94.96 |
| Sphingolipid Metabolism and Signaling | Lifetime | 379 | US 149 | 94.52 |
| Lymphatic System and Diseases | Lifetime | 583 | US 208 | 90.25 |
| Apelin-related biomedical research | Lifetime | 610 | US 180 | 88.02 |
| Adipose Tissue and Metabolism | 2021-2025 | 2 | US 1 | 99.55 |
| Adipokines, Inflammation, and Metabolic Diseases | 2021-2025 | 5 | US 2 | 99.29 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 16 | US 9 | 98.65 |
| Lipid metabolism and disorders | 2021-2025 | 90 | US 30 | 89.87 |
| Diabetes and associated disorders | 2021-2025 | 719 | US 245 | 87.83 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 773 | US 188 | 81.93 |
| Body Contouring and Surgery | 2021-2025 | 367 | US 147 | 79.88 |
| Regulation of Appetite and Obesity | 2021-2025 | 424 | US 127 | 78.75 |
| Fibroblast Growth Factor Research | 2021-2025 | 329 | US 104 | 75.06 |
| Sphingolipid Metabolism and Signaling | 2021-2025 | 331 | US 104 | 72.71 |
| Lymphatic System and Diseases | 2021-2025 | 801 | US 270 | 63.34 |
